Anushka R. Patel , Nuwan Jayawickreme , Vanessa Visquerra , Kelly Dixon , Vikram Patel
{"title":"Empirically supported treatments for all: Realizing equitable coverage of care for trauma survivors globally","authors":"Anushka R. Patel , Nuwan Jayawickreme , Vanessa Visquerra , Kelly Dixon , Vikram Patel","doi":"10.1016/j.brat.2025.104757","DOIUrl":null,"url":null,"abstract":"<div><div>Global mental health is focused on reducing inequities in treatment access for mental health disorders. A core social determinant of mental health is trauma (e.g., violence, disasters, wars), contributing to myriad psychosocial outcomes such as posttraumatic stress disorder (PTSD), depression, anxiety, and functional impairment. Despite the development of numerous efficacious empirically supported treatments (ESTs), trauma survivors remain a particularly vulnerable group and rarely receive quality trauma-informed treatment. In this paper, we argue that in order to reduce global inequities in mental health treatment access, we need to <em>fully</em> embrace Chambless and Hollon's (1998) criteria for ESTs – that they be efficacious, effective in routine clinical contexts, feasible to deploy and scale up, and cost-effective. While the field of clinical science has made impressive strides in developing efficacious treatments, we argue that we ought to place greater emphasis on an EST being effective across contexts, feasible for delivery by a wide cadre of providers, and cost-effective to scale to improve equity. We discuss efforts in the field of global mental health that use innovative paradigms to fully realize the latter criteria, which have been under-appreciated in clinical science. We conclude with recommendations to improve EST access by applying an equity lens <em>within and between contexts</em>.</div></div>","PeriodicalId":48457,"journal":{"name":"Behaviour Research and Therapy","volume":"190 ","pages":"Article 104757"},"PeriodicalIF":4.2000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Behaviour Research and Therapy","FirstCategoryId":"102","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0005796725000798","RegionNum":2,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Global mental health is focused on reducing inequities in treatment access for mental health disorders. A core social determinant of mental health is trauma (e.g., violence, disasters, wars), contributing to myriad psychosocial outcomes such as posttraumatic stress disorder (PTSD), depression, anxiety, and functional impairment. Despite the development of numerous efficacious empirically supported treatments (ESTs), trauma survivors remain a particularly vulnerable group and rarely receive quality trauma-informed treatment. In this paper, we argue that in order to reduce global inequities in mental health treatment access, we need to fully embrace Chambless and Hollon's (1998) criteria for ESTs – that they be efficacious, effective in routine clinical contexts, feasible to deploy and scale up, and cost-effective. While the field of clinical science has made impressive strides in developing efficacious treatments, we argue that we ought to place greater emphasis on an EST being effective across contexts, feasible for delivery by a wide cadre of providers, and cost-effective to scale to improve equity. We discuss efforts in the field of global mental health that use innovative paradigms to fully realize the latter criteria, which have been under-appreciated in clinical science. We conclude with recommendations to improve EST access by applying an equity lens within and between contexts.
期刊介绍:
The major focus of Behaviour Research and Therapy is an experimental psychopathology approach to understanding emotional and behavioral disorders and their prevention and treatment, using cognitive, behavioral, and psychophysiological (including neural) methods and models. This includes laboratory-based experimental studies with healthy, at risk and subclinical individuals that inform clinical application as well as studies with clinically severe samples. The following types of submissions are encouraged: theoretical reviews of mechanisms that contribute to psychopathology and that offer new treatment targets; tests of novel, mechanistically focused psychological interventions, especially ones that include theory-driven or experimentally-derived predictors, moderators and mediators; and innovations in dissemination and implementation of evidence-based practices into clinical practice in psychology and associated fields, especially those that target underlying mechanisms or focus on novel approaches to treatment delivery. In addition to traditional psychological disorders, the scope of the journal includes behavioural medicine (e.g., chronic pain). The journal will not consider manuscripts dealing primarily with measurement, psychometric analyses, and personality assessment.